PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Center for Lymphoma, Massachusetts General Hospital Cancer Center, Boston, MA.\', \'Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard, Cambridge, MA.\', \'Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA.\', \'Immune Monitoring Laboratory, Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Boston, MA; and.\', \'Department of Allergy and Immunology.\', \'Department of Pharmacy.\', \'Department of Infectious Diseases, and.\', \'Department of Pathology, Massachusetts General Hospital, Boston, MA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1182/bloodadvances.2021006627
?:doi
?:hasPublicationType
?:journal
  • Blood advances
is ?:pmid of
?:pmid
?:pmid
  • 35073571
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Humoral and cellular immunogenicity of SARS-CoV-2 vaccines in chronic lymphocytic leukemia: a prospective cohort study.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all